Starting Doses
Before You Start
Get a baseline blood test first
Before taking any hormones, get a baseline blood test including:
- E2 (estradiol)
- Total T (testosterone)
- LH, FSH
- SHBG
- CBC (complete blood count)
- Comprehensive metabolic panel (liver, kidney function)
- Lipid panel
This gives you a reference point to measure changes against.
Doses below are for adults (18+).
Adolescent-specific guidance is provided in the section below.
Adolescent Dosing (Under 18)
Adolescent hormone therapy follows a start low, go slow approach to mimic the gradual pace of endogenous puberty. These guidelines are based on WPATH SOC8 and Endocrine Society (2017) recommendations.
Important
This guide does not recommend DIY HRT for minors without medical supervision. Hormone therapy in adolescents ideally involves a multidisciplinary team including a qualified provider. The information below is provided for educational purposes and to help adolescents and families understand standard protocols.
General Principles for Adolescents
- Pre-pubertal children: Hormone therapy is not recommended — social transition and supportive care are the standard of care .
- Tanner stage 2+: Puberty blockers (GnRH agonists) are the first-line intervention if suppression of natal puberty is desired .
- Gender-affirming hormones are typically added around age 14–16, after a multidisciplinary team confirms persistence of gender incongruence and the adolescent has sufficient capacity for informed consent .
- The goal is to mimic pubertal hormone levels, gradually increasing over 2–3 years until adult doses are reached .
Estrogen — Pubertal Induction (Early to Mid Puberty)
For adolescents in early puberty (Tanner stage 2–3), estrogen is introduced at very low doses and increased every 6 months:
| Phase | Oral Estradiol | Transdermal Estradiol | Duration |
|---|---|---|---|
| Starting dose | 0.25–0.5 mg/day (or 5 µg/kg/day) | 6.25–12.5 µg/24h (¼–½ of a 25 µg patch) | 6 months |
| Step 2 | 0.5–1 mg/day (or 10 µg/kg/day) | 25 µg/24h | 6 months |
| Step 3 | 1–2 mg/day (or 15 µg/kg/day) | 37.5 µg/24h | 6 months |
| Step 4 | 2–4 mg/day (or 20 µg/kg/day) | 50 µg/24h | 6 months |
| Adult maintenance | 2–6 mg/day | 50–200 µg/24h | Ongoing |
Doses per Endocrine Society (2017) pubertal induction protocol and Hopkins Adolescent Dosing Guide .
Estrogen — Post-Pubertal Adolescents (Tanner Stage 5)
Adolescents who have completed natal puberty can increase doses more rapidly:
| Timeline | Oral Estradiol | Transdermal Estradiol |
|---|---|---|
| Months 0–6 | 1 mg/day | 25–50 µg/24h |
| Month 6+ | 2 mg/day | 50–100 µg/24h |
| Adult maintenance | 2–6 mg/day | 50–200 µg/24h |
Anti-Androgens in Adolescents
Age-Based Summary
| Age Range | Typical Approach |
|---|---|
| Under 13 | Social transition + supportive care. Puberty blockers at Tanner stage 2, if indicated. |
| 13–15 | Puberty blockers if not already started. Low-dose estrogen (pubertal induction protocol). Increase slowly every 6 months. |
| 16–17 | May follow post-pubertal protocol (more rapid increase). Full adult doses may be appropriate by age 17–18, guided by levels and response. |
| 18+ | Adult dosing as below. |
Note on HRT Dosing
Any regimen: There's no strong evidence that starting with a low estradiol dose and slowly increasing it is better than starting at a moderate dose. Some anecdotes suggest it may improve breast development or feminisation, but these claims lack clinical support. While generally not harmful, lower starting doses may make testosterone suppression more difficult. You can experiment if you choose.
For regimens with antiandrogens: There is usually no reason to start HRT on a lower than standard dose of antiandrogen — you should go directly onto a typical dose of antiandrogen and adjust accordingly if needed.
For regimens with oral or sublingual/buccal estradiol: To dose pills accurately, you may need a pill cutter, which you can find on Amazon or at most pharmacies. Check your HRT pill type to see how it should be split to match your dose. For example, if you take 2 mg of estradiol three times a day but only have 4 mg pills, you'll need to cut each pill in half.
Antiandrogen + Estradiol Dosing
The following example regimens use typical doses of estradiol on the higher end of what would be considered a moderate dose. Adjust accordingly if you have access to blood testing (see Blood Testing below).
Cyproterone Acetate
If you take cyproterone, you will need a pill cutter! (Pill cutters are sold at any pharmacy over the counter or online.) Cyproterone tablets are almost always 25–50 mg tablets (way over a recommended dose). It is not recommended to go above 12.5 mg of cyproterone daily. Increase your estrogen dosage if testosterone is not adequately suppressed instead. Cyproterone acetate is taken orally.
| Method | Cyproterone Acetate Dosage | Estradiol Form | Total Daily Estradiol |
|---|---|---|---|
| Oral | 6.25–12.5 mg once a day | 3 mg oral tablets twice daily | 6 mg |
| Sublingual | 6.25–12.5 mg once a day | 1 mg sublingual/buccal tablets three times daily | 3 mg |
| Transdermal | 6.25–12.5 mg once a day | 200 µg patches changed twice weekly* | ~200 µg daily equivalent |
| Topical | 6.25–12.5 mg once a day | 4 mg gel once daily | 4 mg |
Cyproterone acetate may be effective for many people when taken at a dosage of 12.5 mg every other day. Blood tests would be useful to check if this adjustment may work for you.
*Estradiol patches usually come in a form intended to be changed every 3–4 days, although some may allow for weekly use. Check the packaging to be sure how often you are meant to change your patch.
Bicalutamide
Reminder! Bicalutamide may cause blood testosterone levels to increase slightly, so even though your T may be adequately blocked, your testosterone levels on a blood test will likely show quite high levels. Bicalutamide also has a long half-life, which means it doesn't really matter what time you take it every day, as long as you take it every day. 50 mg daily is almost always enough to ensure adequate testosterone suppression when combined with estradiol. Bicalutamide is taken orally.
| Method | Bicalutamide Dosage | Estradiol Form | Total Daily Estradiol |
|---|---|---|---|
| Oral | 50 mg once daily | 3 mg oral tablets twice daily | 6 mg |
| Sublingual | 50 mg once daily | 1 mg sublingual/buccal tablets three times daily | 3 mg |
| Transdermal | 50 mg once daily | 200 µg patches changed twice weekly* | ~200 µg daily equivalent |
| Topical | 50 mg once daily | 4 mg gel once daily | 4 mg |
*Estradiol patches usually come in a form intended to be changed every 3–4 days, although some may allow for weekly use. Check the packaging to be sure how often you are meant to change your patch.
Relugolix
Relugolix is taken orally once a day, usually in 40 mg pills. From DIY sources, it usually comes in a capsule form. Relugolix does not have the testosterone flare side effect that GnRH agonists have, so you do not have to increase your dose at the start.
| Method | Relugolix Dosage | Estradiol Form | Total Daily Estradiol |
|---|---|---|---|
| Oral | 40 mg once daily | 3 mg oral tablets twice daily | 6 mg |
| Sublingual | 40 mg once daily | 1 mg sublingual/buccal tablets three times daily | 3 mg |
| Transdermal | 40 mg once daily | 200 µg patches changed twice weekly* | ~200 µg daily equivalent |
| Topical | 40 mg once daily | 4 mg gel once daily | 4 mg |
*Estradiol patches usually come in a form intended to be changed every 3–4 days, although some may allow for weekly use. Check the packaging to be sure how often you are meant to change your patch.
Buserelin
Buserelin (sometimes sold as the brand name Suprefact) has a short half-life, so it should be administered three times a day to be effective. You can double the recommended dose of buserelin during the first week to counteract the testosterone flare effect that GnRH agonists have. Alternatively, you can take cyproterone or bicalutamide for the first three weeks on buserelin.
Buserelin comes in a bottle that dispenses a set amount of medicine with each spray (300 µg per spray in these examples).
| Method | Buserelin Dosage | Estradiol Form | Total Daily Estradiol |
|---|---|---|---|
| Oral | 300 µg sprayed three times per day (900 µg/day) | 3 mg oral tablets twice daily | 6 mg |
| Sublingual | 300 µg sprayed three times per day (900 µg/day) | 1 mg sublingual/buccal tablets three times daily | 3 mg |
| Transdermal | 300 µg sprayed three times per day (900 µg/day) | 200 µg patches changed twice weekly* | ~200 µg daily equivalent |
| Topical | 300 µg sprayed three times per day (900 µg/day) | 4 mg gel once daily | 4 mg |
*Estradiol patches usually come in a form intended to be changed every 3–4 days, although some may allow for weekly use. Check the packaging to be sure how often you are meant to change your patch.
Spironolactone
For some individuals, spironolactone may not be able to adequately suppress testosterone levels. It's recommended to get a blood test to monitor your levels to see if this is an effective antiandrogen for you.
| Method | Spironolactone Dosage | Estradiol Form | Total Daily Estradiol |
|---|---|---|---|
| Oral | 200 mg once daily | 3 mg oral tablets twice daily | 6 mg |
| Sublingual | 200 mg once daily | 1 mg sublingual/buccal tablets three times daily | 3 mg |
| Transdermal | 200 mg once daily | 200 µg patches changed twice weekly* | ~200 µg daily equivalent |
| Topical | 200 mg once daily | 4 mg gel once daily | 4 mg |
*Estradiol patches usually come in a form intended to be changed every 3–4 days, although some may allow for weekly use. Check the packaging to be sure how often you are meant to change your patch.
Injection Monotherapy Dosing
Here are some reasonable dosages for estradiol injections used in transfeminine hormone therapy:
| Estradiol Formulation | Recommended Dose | Injection Volume | Frequency |
|---|---|---|---|
| Estradiol Valerate (EV) | 4 mg | 0.1 mL (assuming 40 mg/mL vial) | Every 5 days |
| Estradiol Cypionate (EC) | 4 mg | 0.1 mL (assuming 40 mg/mL vial) | Every 7 days |
| Estradiol Enanthate (EEn) | 4 mg | 0.1 mL (assuming 40 mg/mL vial) | Every 7 days |
| Estradiol Enanthate (EEn) — Alternative | 7 mg | ~0.18 mL (assuming 40 mg/mL vial) | Every 10 days |
| Estradiol Undecylate (EUn) | 24 mg | 0.3 mL (assuming 80 mg/mL vial) | Every 21 days |
| Estradiol Undecylate (EUn) — Alternative | 32 mg | 0.4 mL (assuming 80 mg/mL vial) | Every month (28–31 days) |
Because estradiol undecylate takes longer to accumulate in the body, you may choose, for the first dose only, to take up to 2.5× the standard dose to reach stable levels more quickly. For example, if your intended dose is 32 mg every month, your initial loading dose may be 80 mg (32 × 2.5).
Estradiol Undecylate (EUn)
It is highly recommended to inject estradiol undecylate intramuscularly, as subcutaneous injections may produce unpredictable levels.
Notes on Injection Dosing
- Usually, homebrew estradiol injections are compounded at a concentration of 40 mg/mL, with the exception of estradiol undecylate (EUn), which is usually compounded at 80 mg/mL.
- EEn has two common dosing schedules.
- EUn has two common dosing schedules.
- These are general guidelines for dosing.
- These dosages should give the vast majority of people high enough estradiol levels to suppress testosterone on its own.
Adjust accordingly if you have access to blood testing (see Blood Testing below). Ideally you should be aiming for the lowest possible estradiol levels (that are still above 100 pg/mL at trough) that still adequately suppress testosterone < 50 ng/dL at trough. Though people usually require trough estradiol levels of 200–250 pg/mL to adequately suppress testosterone. ("Trough" refers to your blood levels at the lowest point of your dosage regimen, which is right before you take your next dose.)
Calculating Injection Dosages
Vials of estradiol are usually compounded at 40 mg/mL.
This means that for a 40 mg/mL vial, every 1 mL of liquid will contain 40 mg of estradiol. A 40 mg/mL 10 mL vial will then contain a total of 400 mg of estradiol.
We will unfortunately be doing some math here.
The formula to calculate how much liquid to inject is:
(amount you want to inject) ÷ (concentration of the vial) = amount to inject per dose in mL
Dosing Examples
| Desired Dose | Vial Concentration | Calculation | Injection Volume |
|---|---|---|---|
| 4 mg | 40 mg/mL | 4 ÷ 40 = 0.1 | 0.1 mL |
| 5 mg | 40 mg/mL | 5 ÷ 40 ≈ 0.13 | 0.13 mL |
| 8 mg | 40 mg/mL | 8 ÷ 40 = 0.2 | 0.2 mL |
| 10 mg | 10 mg/mL | 10 ÷ 10 = 1 | 1 mL |
| 10 mg | 20 mg/mL | 10 ÷ 20 = 0.5 | 0.5 mL |
| 10 mg | 40 mg/mL | 10 ÷ 40 = 0.25 | 0.25 mL |
| 10 mg | 80 mg/mL | 10 ÷ 80 ≈ 0.13 | 0.13 mL |
Not too complicated, hopefully! If you still need help with calculating dosages, this is a useful tool.
How to Perform an E Injection
Needles can be bought from any pharmacy over the counter in most countries without a prescription (you may have to ask the pharmacist directly). Most countries also have online sites that sell appropriate injection needles. Amazon is a popular source for those in America.
Injection Supplies
Make sure to buy 1 mL syringes, as the small amounts of fluid we are using for each injection are only easily measured with 1 mL syringes. The more common 3 mL syringes are not ideal due to the difficulty in accurately measuring dosage. It is fine to use 3 mL syringes if you are using estradiol undecylate due to the high injection volumes.
Subcutaneous vs Intramuscular
There are two methods for an E injection:
- Subcutaneous (subq/SQ/SC) — injection into the layer of fat under the skin
- Intramuscular (IM) — injection deep into the muscle underneath the skin and fat
Both methods result in identical absorption rates and levels of the drug (unless you're using estradiol undecylate). Whether you prefer subq or IM is mostly personal preference.
Homebrewed injections typically contain benzyl benzoate (a safe solvent also commonly used in prescription-grade medications), which can cause some minor irritation if injected subcutaneously. Usually there will be less post-injection pain if injected intramuscularly.
Needle Sizes
| Injection Type | Gauge (Thickness) | Needle Length |
|---|---|---|
| Subcutaneous (subq) | 25–30G | ½"–⅝" |
| Intramuscular (IM) | 23–25G | 1"–1½" (1" for thinner people, 1½" for larger people) |
Subq needles are thinner than IM needles, which some people find less intimidating.
Video Guide
There are many online videos and guides for how to administer an intramuscular or subcutaneous injection. Here is a decent one:
Guide by Plume: https://support.getplume.co/support/solutions/articles/72000544742-all-about-injections
Very detailed video guides on both IM and subq injections, with the downside that they are split into multiple long videos.
Note that around 0.1 mL of fluid will be lost with each injection due to needle dead space.
Injections With Antiandrogens
Generally, injections will not need antiandrogens, though if you prefer to take a lower injection dosage, you may need an antiandrogen (also note that lower injection dosages may require the use of fixed needle, insulin-type syringes of 0.3 mL or 0.5 mL to accurately measure dosage).
Here are some recommended injection dosages if you are taking antiandrogens along with it (refer to the antiandrogen dosing tables above for recommended antiandrogen dosing):
| Estradiol Formulation | Recommended Dose | Injection Volume | Frequency |
|---|---|---|---|
| Estradiol Valerate (EV) | 2 mg | 0.05 mL (assuming 40 mg/mL vial) | Every 5 days |
| Estradiol Cypionate (EC) | 2 mg | 0.05 mL (assuming 40 mg/mL vial) | Every 7 days |
| Estradiol Enanthate (EEn) | 2 mg | 0.05 mL (assuming 40 mg/mL vial) | Every 7 days |
| Estradiol Enanthate (EEn) — Alternative | 3 mg | ~0.075 mL (assuming 40 mg/mL vial) | Every 10 days |
| Estradiol Undecylate (EUn) | 12 mg | 0.15 mL (assuming 80 mg/mL vial) | Every 21 days |
| Estradiol Undecylate (EUn) — Alternative | 16 mg | 0.2 mL (assuming 80 mg/mL vial) | Every month |
Blood Testing
Cost
$50–$150 per test, depending on source.
Blood testing is highly recommended, but not absolutely mandatory — especially if not particularly affordable or feasible.
It is recommended to do your first blood test within the first 3 months, and then adjust your dosage if necessary. If you change your dosage, try to retest again within 3 months. If your levels look good, blood testing frequency can be reduced to just once a year.
Here are some sources of private blood testing if you cannot access blood testing through the medical system: Blood Testing Sources.
When to Test
Get your estradiol (E2) and total testosterone (T) tested every time. Get your blood taken as close as possible to your next scheduled injection/dose (test your blood as far away as possible from a previous dose, right before your next scheduled dose — preferably the day of your shot, or the day before). Your blood levels of estradiol and testosterone when taken at this time are called trough levels, because they are the levels of E2 and T that are present in your body at the lowest point in your HRT dosing regimen.
Trough levels are most useful for injection monotherapy — for determining if your testosterone is adequately suppressed at the lowest point of your injection cycle.
Target Levels
The most essential component of transfeminine HRT is to get:
- Total testosterone (T) below 50 ng/dL (< 1.73 nmol/L)
- Estradiol (E2) above 100 pg/mL (367 pmol/L)
Footnotes
However, I strongly recommend regular blood tests (every 3 months) to get liver function tests (ALT/AST) if you are taking bicalutamide, due to the extremely low but still present risk of severe liver toxicity. You can stop these tests after about a year or so if your liver enzymes are normal on bica after a year — you're fine.
Most private blood testing lets you print off a requisition form, which you can bring to a local blood lab to get your blood drawn. You don't have to mail anything in or take your blood at home. In some places like the UK, you will get sent a blood testing kit, which you can take to a local clinic to get your blood drawn.
Different abbreviations of subcutaneous in common usage include: subq/subQ, SQ and SC.
References
Hembree WC, et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. JCEM, 102(11):3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
Deutsch MB, ed. (2016). Guidelines for the Primary and Gender-Affirming Care of Transgender and Gender Nonbinary People. UCSF Transgender Care. https://transcare.ucsf.edu/guidelines
Coleman E, et al. (2022). Standards of Care for the Health of Transgender and Gender Diverse People, Version 8. International Journal of Transgender Health, 23(S1). https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Coleman E, et al. (2022). SOC8 — Chapter 6: Adolescents. WPATH. https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Hembree WC, et al. (2017). Section 1.4: Prepubertal children. JCEM, 102(11):3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
Hembree WC, et al. (2017). Section 2.1–2.3: Pubertal suppression. JCEM, 102(11):3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
Coleman E, et al. (2022). SOC8 — Statement 6.5: Sex hormone therapy in adolescents. International Journal of Transgender Health, 23(S1). https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Hembree WC, et al. (2017). Table 8: Protocol for induction of puberty. JCEM, 102(11):3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
Coleman E, et al. (2022). SOC8 — Statement 6.2: GnRH agonists in adolescents. International Journal of Transgender Health, 23(S1). https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Coleman E, et al. (2022). SOC8 — Chapter 12: Hormone Therapy (safety considerations). International Journal of Transgender Health, 23(S1). https://www.tandfonline.com/doi/full/10.1080/26895269.2022.2100644
Hembree WC, et al. (2017). Table 8: Induction of puberty with oral/transdermal 17β-estradiol. JCEM, 102(11):3869–3903. https://academic.oup.com/jcem/article/102/11/3869/4157558
Hedian HF, et al. (2024). Dosing Guide: Gender Affirming Hormone Therapy for Transgender and Gender Diverse Adolescents. Johns Hopkins Medicine. https://www.hopkinsmedicine.org/-/media/center-for-transgender-health/documents/adolescentdosingguide41224.pdf